Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout.
Open Access
- 1 June 1985
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 44 (6) , 390-394
- https://doi.org/10.1136/ard.44.6.390
Abstract
The very low density (VLDL) apolipoproteins of 12 male patients with gout have been studied by analytical isoelectric focusing. The relative percentage distribution of the C apolipoproteins was calculated and compared with that from 12 normolipidaemic and 12 'lipid-matched' controls. In the gout patients apolipoprotein CII (apo CII) represented 19.6% of the VLDL C proteins and the CII/CIII2 ratio was 0.57. In the normolipidaemic controls apo CII represented 28.8% and in the lipid-matched controls 33.1% of VLDL apo C, and the CII/CIII2 ratio approached one in each control group. These differences were significant. This suggests that a reduction in VLDL apo CII may predispose to the hypertriglyceridaemia that is commonly found in patients with gout.Keywords
This publication has 21 references indexed in Scilit:
- An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III.Journal of Clinical Investigation, 1982
- Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.Journal of Clinical Investigation, 1980
- HYPERTRIGLYCERIDÆMIA ASSOCIATED WITH AN ABNORMAL TRIGLYCERIDE-RICH LIPOPROTEIN CARRYING EXCESS APOLIPOPROTEIN C-III-2The Lancet, 1979
- Inheritance of Apolipoprotein C-II Deficiency with Hypertriglyceridemia and PancreatitisNew England Journal of Medicine, 1978
- Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-IINew England Journal of Medicine, 1978
- Deposition of urate crystals in goutArthritis & Rheumatism, 1975
- Gout and hyperlipidaemia.Annals of the Rheumatic Diseases, 1974
- Plasma lipid levels in gout.Annals of the Rheumatic Diseases, 1972
- Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoproteinBiochemical and Biophysical Research Communications, 1972
- A specific apoprotein activator for lipoprotein lipaseBiochemical and Biophysical Research Communications, 1970